Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHENZHEN STOCK EXCHANGE  >  BGI Genomics Co., Ltd.    300676   CNE100003449

BGI GENOMICS CO., LTD.

(300676)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

China's BGI wins 1.5 mln coronavirus test kit order from Ethiopia

09/23/2020 | 03:07am EST

BEIJING, Sept 23 (Reuters) - Ethiopia has agreed to purchase 1.5 million coronavirus testing kits that will be manufactured at a factory in the African country that has been newly built by China's BGI Group, China's state media agency Xinhua said late on Tuesday.

The BGI factory, the first coronavirus test production facility in Ethiopia that opened earlier this month, is designed to be able to make 6-8 million tests in a year and can expand the annual capacity to up to 10 million in accordance with local demand, Xinhua reported.

BGI, which makes genome sequencing and medical devices, is hoping to use its footprint in Ethiopia in expanding its supplies to other African countries, Xinhua quoted a BGI official as saying in a separate report on Wednesday.

BGI did not immediately respond to a request for comment.

BGI Group's unit BGI Genomics had said it supplied over 35 million coronavirus testing kits overseas and built 58 labs in 18 countries as of June 30.

The Ethiopia factory could be later converted to make test kits for HIV, malaria and tuberculosis once the COVID-19 pandemic ends, Xinhua said.

Ethiopia, one of the countries that has the most new daily infections on average in Africa, has reported 69,709 infections and 1,108 coronavirus-related deaths since the pandemic began. https://tmsnrt.rs/32UVHhm (Reporting by Roxanne Liu and Tony Munroe in Beijing, Editing by Raju Gopalakrishnan)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
BGI GENOMICS CO., LTD. 0.26% 129.63 End-of-day quote.88.69%
DOW JONES AFRICA TITANS 50 INDEX 0.77% 503.73 Delayed Quote.-7.38%
S&P AFRICA 40 INDEX 0.89% 163.02 Delayed Quote.-6.82%
All news about BGI GENOMICS CO., LTD.
09/23China's BGI wins 1.5 million coronavirus test kit order from Ethiopia
RE
09/23China's BGI wins 1.5 mln coronavirus test kit order from Ethiopia
RE
08/27BGI GENOMICS : WHO says it is in talks with China's BGI on test kit after Swedis..
RE
08/26BGI GENOMICS : China's BGI defends COVID-19 test kit after Swedish criticism
RE
08/24BGI GENOMICS CO., LTD. : half-yearly earnings release
08/05SPECIAL REPORT : COVID opens new doors for China's gene giant
RE
07/22BGI GENOMICS : Chinese genetics company BGI denies U.S. human rights accusations
RE
07/21U.S. adds 11 firms to economic blacklist over China's treatment of Uighurs
RE
07/20U.S. adds 11 firms to economic blacklist over China's treatment of Uighurs
RE
07/14BGI GENOMICS : China's BGI forecasts 700% jump in first-half profit due to COVID..
RE
More news
Financials
Sales 2020 8 985 M 1 367 M 1 367 M
Net income 2020 3 530 M 537 M 537 M
Net Debt 2020 - - -
P/E ratio 2020 14,7x
Yield 2020 0,15%
Capitalization 51 346 M 7 809 M 7 809 M
Capi. / Sales 2020 5,71x
Capi. / Sales 2021 9,58x
Nbr of Employees -
Free-Float 100,0%
Chart BGI GENOMICS CO., LTD.
Duration : Period :
BGI Genomics Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BGI GENOMICS CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price
Last Close Price 129,63 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Ye Yin General Manager & Director
Jian Wang Chairman
Song Gang Li Chairman-Supervisory Board
Yi Qing Chen Chief Financial Officer
Jun Wang Director
Sector and Competitors
1st jan.Capitalization (M$)
BGI GENOMICS CO., LTD.88.69%7 770
EXACT SCIENCES CORPORATION26.80%18 648
GUARDANT HEALTH, INC.44.61%11 297
INVITAE CORPORATION189.21%8 243
ADAPTIVE BIOTECHNOLOGIES CORPORATION50.43%6 156
IOVANCE BIOTHERAPEUTICS, INC.34.25%5 451